不可切除的hcc患者预后仍较差，治疗选择有限，手术切除后复发率较高。 尽管免疫检查点阻断疗法（ICB）改变了HCC的治疗，但它仅能在少数患者中 ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

Patient (pt) characteristics, treatment patterns, and outcomes in unresectable hepatocellular carcinoma (uHCC) treated with first-line (1L) systemic therapy in the United States (US). Patterns of ...

Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.

Results of CHANCE 2005/CARES-005 study were unveiled by Dr Gao-Jun Teng from Zhongda Hospital, Southeast University, China, ...

"The CARES-oo5 study showed a clinically meaningful and statistically significant improvement in the primary endpoint of PFS for unresectable HCC who received TACE plus immunotherapy-based ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...